Empowering health-tech companies worldwide to collaborate efficiently on personalizing health

Solutions

  
    FactsOur opportunities are focused where we can make the most impact

“So we need two things: first, we need ways of predicting and detecting disease well before it becomes life threatening; and second, we need medicines that work for you and your unique body.”— Pieter Cullis

Source: The Personalized Medicine Revolution: How Diagnosing and Treating Disease Are About to Change Forever
“Discoveries about genetics are not limited to just those 6,000 conditions of a strongly hereditary nature, however. We are now in the midst of a genetic revolution that will touch all of us in numerous ways.” — Francis S. Collins

Source: The Language of Life: DNA and the Revolution in Personalized Medicine
“The wellness and prevention market will outgrow the health care market." — Leroy Hood

Source: The pioneer of systems biology and the president and co-founder of Institute for Systems Biology in Seattle
“Medicine is still all about treating populations, not people - one-size-fits all treatments and diagnoses.” — Eric Topol

Source: Professor of Molecular Medicine at The Scripps Research Institute

Get Started

Contact Us →

About Us

We are a team of healthcare executives with deep understanding and expertise in science, technology, product and business development on an international scale

Hossein Fakhrai-Rad, PhD

Founder & Managing Partner

Karolinska Institute, Stanford University,
ParAllele Bioscience, Affymetrix,
BaseHealth, Genalyte

Tamer Karsidag, MD FACS FEBS

Strategic Partner – Türkiye

Istanbul University,
St. London’s George Hospital,
USC, UCLA, Acibadem University

Massimo Delledonne, PhD

Strategic Partner – Italy

Professor of Genetics,
Verona University

Dr. Luthman holds an emeritus professorship at the Lund University in Sweden. He is internationally recognized in the fields of genomics, biochemistry, and molecular biology. He made a significant contribution to genetic research on type 2 diabetes through the identification of a High-Resolution Quantitative Trait Locus Analysis Reveals Multiple Diabetes Susceptibility Loci at Karolinska Institute.

Hamid Faraji, MD

Strategic Partner – UAE

Head of Rehabilitation Department at Dubai Center for Special Needs

Dr. Faraji has over 30 years of experience in a diversity of medicine-related careers, including the last 17 years in the domain of special needs and rare diseases. He is currently working as the head of rehabilitation and medical director in the center for people of determination in Dubai.

Holger Luthman, PhD

Strategic Partner – Sweden

Professor Emeritus of Genomics,
Lund University

Dr. Delledonne is a Professor of Genetics at the Department of Biotechnology, University of Verona in Italy. He coordinates an extensive program of research characterized by an interdisciplinary approach that connects genetics, molecular biology, bioinformatics, and genomics, specializing in human genome sequencing and interpretation in a clinical setting.

Empowering health-tech companies worldwide to collaborate efficiently on personalizing health

Solutions

Facts

Our opportunities are focused where we can make the most impact

“So we need two things: first, we need ways of predicting and detecting disease well before it becomes life threatening; and second, we need medicines that work for you and your unique body.”— Pieter Cullis

“Discoveries about genetics are not limited to just those 6,000 conditions of a strongly hereditary nature, however. We are now in the midst of a genetic revolution that will touch all of us in numerous ways.” — Francis S. Collins

“The wellness and prevention market will outgrow the health care market." — Leroy Hood

“Medicine is still all about treating populations, not people - one-size-fits all treatments and diagnoses.” — Eric Topol